| Brand Name: | Chemfine International |
| Packaging Details: | 25kg/drum (HDPE plastic drum with inner seal) |
Formulation Uses: This raw material is shown for chiral pharmaceutical intermediate synthesis, depsipeptide monomer production, enantioselective chemical synthesis, chiral reference standard preparation, and fine chemical R&D applications.
High Optical Purity D-Enantiomer: (R)-lactic acid with consistent negative specific rotation, providing reliable enantiomeric excess for chiral synthesis and asymmetric transformations.
Versatile Chiral C3 Building Block: The alpha-hydroxy acid structure enables conversion to lactide, depsipeptides, chiral esters and other enantiopure intermediates.
90% Standard Concentration: Supplied as a standard 90% aqueous solution, the most common commercial form for direct use in synthesis and R&D.
Depsipeptide & Drug Intermediate Precursor: Established starting material for biodegradable polymer (PDLA) and chiral pharmaceutical intermediate production.
300 MT Annual Capacity: Reliable supply for fine chemical and pharmaceutical intermediate manufacturers, supported by 25kg HDPE drum packaging.
D-(−)-Lactic acid (CAS 10326-41-7), chemically known as (R)-2-hydroxypropanoic acid, is the dextrorotatory (R)-enantiomer of lactic acid. With the molecular formula C3H6O3 and molecular weight of 90.08 g/mol, it is a colorless to pale yellow viscous liquid (or low-melting solid at temperatures below ~53°C) that is miscible with water, ethanol and glycerol. Unlike L-lactic acid, which is widely produced by fermentation and used in food, cosmetics and biodegradable plastics, D-lactic acid is a specialized chiral building block used in enantioselective synthesis and high-value pharmaceutical intermediate production. Chemfine supplies synthesis and research grade D-(−)-lactic acid for fine chemical and pharmaceutical applications.
Its primary application is as a chiral C3 building block in organic synthesis. The combination of a carboxylic acid group and a chiral alpha-hydroxyl group makes D-lactic acid a versatile starting material for the synthesis of enantiopure intermediates. It is used to produce D-lactide, the monomer for poly(D-lactic acid) (PDLA), which is used as a stereocomplex enhancer in PLA biodegradable plastics. In pharmaceutical synthesis, D-lactic acid serves as a precursor for depsipeptide antibiotics, chiral esters and other optically active intermediates. It is also used as a reference standard in chiral chromatography and analytical method development.
Chemfine supplies D-(−)-lactic acid in 25kg HDPE drums with inner seal, with an annual production capacity of 300 MT. The product is supported by quality documentation including assay, specific rotation, water content, residue on ignition and heavy metal testing. Technical grades and packaging can be matched to existing chiral synthesis and pharmaceutical intermediate production requirements.
| Item | Standard Specification |
|---|---|
| Appearance | Colorless to pale yellow viscous liquid |
| Assay | ≥ 90.0 % |
| Specific Rotation [α]20/D | −13.5° to −15.5° (c=2.5, H2O) |
| Water Content | ≤ 10.0 % |
| Residue on Ignition | ≤ 0.1 % |
| Heavy metals (as Pb) | ≤ 10 ppm |
| Chloride | ≤ 50 ppm |
![]()
Chiral Pharmaceutical Intermediates: Starting material for enantiopure drug intermediates, depsipeptide antibiotics and chiral ester derivatives.
PDLA / Biodegradable Polymer Production: Precursor for D-lactide and poly(D-lactic acid), used as stereocomplex modifier in PLA bioplastics.
Depsipeptide & Oligomer Synthesis: Monomer for sequence-defined depsipeptides and chiral oligomers used in drug delivery and biomaterials research.
Chiral Reference Standards: Certified reference material for chiral HPLC method development and analytical validation.
Fine Chemical R&D: Versatile C3 chiral synthon for academic and industrial enantioselective synthesis programs.
| Brand Name: | Chemfine International |
| Packaging Details: | 25kg/drum (HDPE plastic drum with inner seal) |
Formulation Uses: This raw material is shown for chiral pharmaceutical intermediate synthesis, depsipeptide monomer production, enantioselective chemical synthesis, chiral reference standard preparation, and fine chemical R&D applications.
High Optical Purity D-Enantiomer: (R)-lactic acid with consistent negative specific rotation, providing reliable enantiomeric excess for chiral synthesis and asymmetric transformations.
Versatile Chiral C3 Building Block: The alpha-hydroxy acid structure enables conversion to lactide, depsipeptides, chiral esters and other enantiopure intermediates.
90% Standard Concentration: Supplied as a standard 90% aqueous solution, the most common commercial form for direct use in synthesis and R&D.
Depsipeptide & Drug Intermediate Precursor: Established starting material for biodegradable polymer (PDLA) and chiral pharmaceutical intermediate production.
300 MT Annual Capacity: Reliable supply for fine chemical and pharmaceutical intermediate manufacturers, supported by 25kg HDPE drum packaging.
D-(−)-Lactic acid (CAS 10326-41-7), chemically known as (R)-2-hydroxypropanoic acid, is the dextrorotatory (R)-enantiomer of lactic acid. With the molecular formula C3H6O3 and molecular weight of 90.08 g/mol, it is a colorless to pale yellow viscous liquid (or low-melting solid at temperatures below ~53°C) that is miscible with water, ethanol and glycerol. Unlike L-lactic acid, which is widely produced by fermentation and used in food, cosmetics and biodegradable plastics, D-lactic acid is a specialized chiral building block used in enantioselective synthesis and high-value pharmaceutical intermediate production. Chemfine supplies synthesis and research grade D-(−)-lactic acid for fine chemical and pharmaceutical applications.
Its primary application is as a chiral C3 building block in organic synthesis. The combination of a carboxylic acid group and a chiral alpha-hydroxyl group makes D-lactic acid a versatile starting material for the synthesis of enantiopure intermediates. It is used to produce D-lactide, the monomer for poly(D-lactic acid) (PDLA), which is used as a stereocomplex enhancer in PLA biodegradable plastics. In pharmaceutical synthesis, D-lactic acid serves as a precursor for depsipeptide antibiotics, chiral esters and other optically active intermediates. It is also used as a reference standard in chiral chromatography and analytical method development.
Chemfine supplies D-(−)-lactic acid in 25kg HDPE drums with inner seal, with an annual production capacity of 300 MT. The product is supported by quality documentation including assay, specific rotation, water content, residue on ignition and heavy metal testing. Technical grades and packaging can be matched to existing chiral synthesis and pharmaceutical intermediate production requirements.
| Item | Standard Specification |
|---|---|
| Appearance | Colorless to pale yellow viscous liquid |
| Assay | ≥ 90.0 % |
| Specific Rotation [α]20/D | −13.5° to −15.5° (c=2.5, H2O) |
| Water Content | ≤ 10.0 % |
| Residue on Ignition | ≤ 0.1 % |
| Heavy metals (as Pb) | ≤ 10 ppm |
| Chloride | ≤ 50 ppm |
![]()
Chiral Pharmaceutical Intermediates: Starting material for enantiopure drug intermediates, depsipeptide antibiotics and chiral ester derivatives.
PDLA / Biodegradable Polymer Production: Precursor for D-lactide and poly(D-lactic acid), used as stereocomplex modifier in PLA bioplastics.
Depsipeptide & Oligomer Synthesis: Monomer for sequence-defined depsipeptides and chiral oligomers used in drug delivery and biomaterials research.
Chiral Reference Standards: Certified reference material for chiral HPLC method development and analytical validation.
Fine Chemical R&D: Versatile C3 chiral synthon for academic and industrial enantioselective synthesis programs.